Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
Francesco CardaioliLuca Nai FovinoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Chronic liver disease is associated with increased operative risk of open-heart surgery. In this study, transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) carried high periprocedural mortality, but transfemoral TAVR appeared to be superior to SAVR in terms of long-term survival. Better risk stratification tools are needed for patients with liver dysfunction to avoid futile TAVR and SAVR procedures.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- minimally invasive
- ejection fraction
- left ventricular
- heart failure
- cardiovascular events
- oxidative stress
- coronary artery disease
- cardiovascular disease
- atrial fibrillation
- type diabetes
- drug induced
- replacement therapy
- surgical site infection
- acute coronary syndrome
- catheter ablation